|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06160 BEIGENE
Nominal 
159.600 -7.100 (-4.259%) Ranking Overview
Ranking based on 13 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
1
|
Buy (2)
11
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | -47.00 USD (cts) | |
| Net Profit | -644.79 USD (MIL) | DPS | 0.00 USD (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (USD (MIL)) |
EPS/ ((LPS)(USD (cts)) |
DPS (USD (cts)) |
Net Asset Value per Share (USD) |
Highest (USD (MIL)) |
Lowest (USD (MIL)) |
| 2025 | 52.00 | 6.00 | 0 | -- | 327.00 | -489.50 |
| 2026 | 511.00 | 41.69 | 0 | -- | 912.00 | 134.00 |
| 2027 | 1,060.00 | 971.00 | 0 | -- | 1,503.00 | 1,036.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (USD (MIL)) |
EPS*/ (LPS) (USD (cts)) |
DPS * (USD (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 327.00 | 314.00 | -- | UBS | Buy | 330.00 | 28/02/2025 | |
| 2025 | 47.00 | 44.00 | -- | MORGAN STANLEY | Overweight | 300.00 | 27/02/2025 | |
| 2025 | 165.00 | 155.00 | -- | CLSA | OutPerform | 209.80 | 28/02/2025 | |
| 2025 | 137.00 | 10.00 | -- | CHINA RENAISSANCE | Buy | 208.22 | 17/01/2025 | |
| 2025 | 171.00 | 12.78 | -- | NOMURA | Buy | 188.53 | 17/02/2025 | |
| 2025 | 83.00 | 6.00 | -- | BOCI | Buy | 183.00 | 28/02/2025 | |
| 2025 | -426.00 | -30.60 | -- | CCBI | OutPerform | 173.00 | 13/11/2024 | |
| 2025 | -14.00 | -1.00 | -- | DAIWA | Buy | 171.00 | 13/02/2025 | |
| 2025 | 52.00 | 3.77 | -- | CMB INT'L SEC | Buy | 169.63 | 15/01/2025 | |
| 2025 | -311.00 | -22.90 | -- | BOCOM | Buy | 159.00 | 14/11/2024 | |
| 2025 | -489.50 | -0.40 | -- | MACQUARIE | OutPerform | 156.00 | 12/11/2024 | |
| 2025 | 38.00 | 2.62 | -- | JP MORGAN | Overweight | 140.40 | 18/02/2025 | |
| 2025 | 202.00 | 16.23 | -- | BANK OF AMERICA | Neutral | 125.00 | 17/01/2025 | |
| 2026 | 912.00 | 875.00 | -- | UBS | -- | -- | 28/02/2025 | |
| 2026 | 493.00 | 462.00 | -- | MORGAN STANLEY | -- | -- | 27/02/2025 | |
| 2026 | 669.00 | 627.00 | -- | CLSA | -- | -- | 28/02/2025 | |
| 2026 | 715.00 | 52.00 | -- | CHINA RENAISSANCE | -- | -- | 17/01/2025 | |
| 2026 | 371.00 | 27.76 | -- | NOMURA | -- | -- | 17/02/2025 | |
| 2026 | 511.00 | 37.30 | -- | BOCI | -- | -- | 28/02/2025 | |
| 2026 | 174.00 | 12.50 | -- | CCBI | -- | -- | 13/11/2024 | |
| 2026 | 365.00 | 26.40 | -- | DAIWA | -- | -- | 13/02/2025 | |
| 2026 | 674.00 | 48.92 | -- | CMB INT'L SEC | -- | -- | 15/01/2025 | |
| 2026 | 134.00 | 9.80 | -- | BOCOM | -- | -- | 14/11/2024 | |
| 2026 | 218.20 | 0.20 | -- | MACQUARIE | -- | -- | 12/11/2024 | |
| 2026 | 593.00 | 41.69 | -- | JP MORGAN | -- | -- | 18/02/2025 | |
| 2026 | 828.00 | 66.54 | -- | BANK OF AMERICA | -- | -- | 17/01/2025 | |
| 2027 | 1,503.00 | 1,442.00 | -- | UBS | -- | -- | 28/02/2025 | |
| 2027 | 1,036.00 | 971.00 | -- | CLSA | -- | -- | 28/02/2025 | |
| 2027 | 1,060.00 | 77.50 | -- | BOCI | -- | -- | 28/02/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 03/03/2025 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD -644,786 |
| %Change | -26.871% |
| EPS / (LPS) | USD -0.470 |
| NBV Per Share ($) | USD 2.406 |